Keyphrases
COVID-19
100%
Spain
88%
Barcelona
50%
Whole Genome Sequencing
48%
Catalonia
44%
Influenza B
40%
Virus
40%
COVID-19 Serology
40%
Reinfection
40%
Reassortant
40%
Tertiary Hospital
40%
Severe Acute Respiratory Syndrome coronavirus-2 Vaccine
40%
Analytical Evaluation
40%
Hematological Malignancies
40%
Rapid Diagnostic Test
40%
Messenger RNA (mRNA)
40%
Dried Blood Spots
40%
Electrochemiluminescence Immunoassay (ECLIA)
40%
Humoral Response
40%
Plasmonic Biosensor
40%
Chronic Chagas Disease
40%
Label-free
40%
Humoral Immunogenicity
40%
Cellular Response
40%
Community Screening
40%
Clinical Validation
40%
Highly Sensitive
40%
Clinical Manifestations
40%
HIV Patients
40%
Syphilis
40%
Risk Factors
40%
Congenital Syphilis
40%
Reassortment
33%
Yamagata
33%
Blood Samples
32%
Dried Blood Sample
32%
Trypanosoma
24%
Enzyme-linked Immunosorbent Assay (ELISA)
24%
COVID-19 Negative
20%
Protein Sensor
20%
Multi-antigen
20%
Proprietary Technology
20%
Biosensor Assay
20%
Plasmonic Devices
20%
Limit of Detection
20%
Negative Samples
20%
Anti-CD20 Therapy
20%
Technology-based
20%
COVID-19 Positive
20%
Diagnostic Sensitivity
20%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Immunoassay
46%
Hematologic Malignancy
40%
Rapid Diagnostic Test
40%
Dried Blood Spot
40%
Humoral Immunity
40%
Immunogenicity
40%
COVID-19
40%
Reinfection
40%
Chagas Disease
40%
Messenger RNA
40%
Human Immunodeficiency Virus
40%
Syphilis
40%
Diagnosis
30%
Trypanosoma
30%
Enzyme Linked Immunosorbent Assay
30%
CD20
20%
Immunosuppressive Treatment
13%
Graft Versus Host Reaction
13%
Lymphocytopenia
13%
Odds Ratio
13%
Chancre
13%
Disease Management
10%
Serological Test
10%
Immunoglobulin
10%
Guanine Nucleotide Binding Protein
10%
Public Health
10%
Diseases
10%
Sensitivity and Specificity
10%
Rapid Test
10%
Polyclonal Antibody
10%
Screening
10%
Blood Sampling
10%
Immunoaffinity Chromatography
10%
Biochip
10%
Treponema pallidum
8%
Whole Genome Sequencing
8%
T-Cell Response
6%
Combination Therapy
6%
Cell Count
6%
Aplasia
6%
B Cell
6%
T Cell
6%
RNA Vaccine
6%
Hypogammaglobulinemia
6%
Interferon
6%
Immunosuppressive Drug
6%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
60%
Immunoassay
46%
Immunogenicity
40%
Humoral Immunity
40%
Lineages
40%
Serology
40%
COVID-19
40%
Reassortment
40%
Electrochemiluminescence
40%
Whole Genome Sequencing
40%
Influenza
40%
Chagas Disease
40%
Immunology
30%
Trypanosoma
30%
Enzyme-Linked Immunosorbent Assay
30%
Cladistics
21%
CD20
20%
Immunosuppressive Drug
20%
Graft-Versus-Host Disease
13%
Lymphocytopenia
13%
T Cell
13%
Blood Plasma
10%
Blood Sampling
10%
Intravenous Immunoglobulin
10%
Immunoaffinity Chromatography
10%
Screening
10%
Polyclonal Antibody
10%
RNA Vaccine
6%
Interferon Type I
6%
B Cell
6%
Cell Count
6%
Hypogammaglobulinemia
6%
Antibody Titer
6%
